The Leaving (feat. VRNA), by NEW RISEN THRONE

from the album The Journey to Reach the Fathers

Cyclic Law

With reports of a potential $10 billion buyout by Merck, the question for $VRNA isn't if it will move, but how. Forget the noise; the trend is what pays. I'm breaking down the key chart levels to watch.

#VRNA
https://overwi.se/2025/07/09/vrna-8-jul-2025/

VRNA 8 Jul 2025 - Trend trading

Verona Pharma (VRNA) | Equity Analysis Infographic Verona Pharma plc A New Era in Respiratory Treatment An infographic analysis of the biopharmaceutical company following the landmark FDA approval of its COPD drug, Ohtuvayre®, and its transition to a commercial-stage entity. Market Capitalization $7.7B+ A significant valuation reflecting investor optimism following a major regulatory milestone. Key […]

Trend trading
Verona Pharma: Strong Stock Growth Potential From A Promising New Drug

Verona Pharma's ensifentrine achieved positive results in a Phase 3 study with an indication for COPD. See what makes VRNA stock a strong buy.

Seeking Alpha